发明名称 TETRACYCLIC DERIVATIVES, PROCESS OF PREPARATION AND USE
摘要 A compound of formula (I) and salts and solvates thereof, in which: R0 represents hydrogen, halogen or C1-6 alkyl; R1 represents hydrogen, C1-6alkyl, C2-6 alkenyl, C2-6 alkynyl, haloC1-6alkyl, C3-8cycloalkyl, C3-8cycloalkylC1-3alkyl, arylC1-3alkyl or heteroarylC1-3alkyl; R2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan and pyridine or an optionally substituted bicyclic ring (a) attached to the rest of the molecule via one of the benzene ring carbon atoms and wherein the fused ring (A) is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur and nitrogen; and R3 represents hydrogen or C1-3 alkyl, or R1 and R3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and selective inhibitor of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase (cGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders.
申请公布号 CA2181377(A1) 申请公布日期 1995.07.27
申请号 CA19952181377 申请日期 1995.01.19
申请人 ICOS CORPORATION 发明人 DAUGAN, ALAIN CLAUDE-MARIE
分类号 C07D471/04;A01K67/033;A01N63/00;A61K31/395;A61K31/495;A61K31/4985;A61P1/00;A61P1/12;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/02;A61P13/12;A61P15/00;A61P27/02;A61P27/06;A61P27/14;A61P27/16;A61P29/00;A61P37/08;A61P43/00;C07D209/08;C07D209/14;C07D209/20;C07D471/14;(IPC1-7):C07D471/14;C07D401/12;C07D405/12;C07D409/12 主分类号 C07D471/04
代理机构 代理人
主权项
地址